Transcription of Twinrix Product Monograph - GSK
{{id}} {{{paragraph}}}
Product Monograph . Twinrix . Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine Suspension for injection Active immunizing agent against infection by hepatitis A and hepatitis B virus ATC Code: J07BC20. GlaxoSmithKline Inc. 7333 Mississauga Road Mississauga, Ontario L5N 6L4. Date of Revision: November 30, 2018. Submission Control No: 2018 GSK group of companies or its licensor. Trademarks are owned by or licensed to the GSK group of companies. Page 1 of 33. Table of Contents PART I: HEALTH PROFESSIONAL INFORMATION ..3. SUMMARY Product INFORMATION ..3. INDICATIONS AND CLINICAL USE ..3. CONTRAINDICATIONS ..4. WARNINGS AND PRECAUTIONS ..4. ADVERSE DRUG INTERACTIONS ..9. DOSAGE AND ADMINISTRATION ..10. OVERDOSAGE ..14. ACTION AND CLINICAL PHARMACOLOGY ..14. STORAGE AND STABILITY ..18. DOSAGE FORMS, COMPOSITION AND PACKAGING.
Nov 30, 2018 · PRODUCT MONOGRAPH . TWINRIX. Combined hepatitis A (inactivated) and hepatitis B (recombinant) vaccine . Suspension for injection . ... • For a complete listing, see the DOSAGE FORMS, COMPOSITION AND PACKAGING section of the product monograph. As with other vaccines, the administration of TWINRIX should be postponed in subjects ...
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}